We now know that cancer is many different diseases, with great variation even within a
single histological subtype. With the current emphasis on developing personalized …

Long non-coding RNAs (lncRNAs) have been demonstrated to have a crucial function in the
modulation of the activity of genes, impacting a variety of homeostatic processes involving …

Abstract Background MicroRNAs (miRNAs) and Twist1-induced epithelial-mesenchymal
transition (EMT) in cancer cell dissemination are well established, but the involvement of …

Lung cancer is associated with a high mortality, with around 1.8 million deaths worldwide in
2018. Non-small-cell lung cancer (NSCLC) accounts for around 85% of cases and, despite …

We present an update of EpiFactors, a manually curated database providing information
about epigenetic regulators, their complexes, targets, and products which is openly …

The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …

Objective This study aimed to investigate the relationship among miR-145-5p, ANGPT2 and
the NOD_LIKE_RECEPTOR pathway, thereby revealing the molecular mechanism of these …

Cancer is the manifestation of changes and mutations in genetic and epigenetic levels. Non-
coding RNAs (ncRNAs) are commonly dysregulated in disease pathogenesis, and their role …

Osteosarcoma (OS) is a type of malignant primary bone cancer, which is highly aggressive
and occurs more commonly in children and adolescents. Thus, novel potential drugs and …